| Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, ... Nature medicine 28 (1), 125-135, 2022 | 101 | 2022 |
| Translational models of tumor angiogenesis: a nexus of in silico and in vitro models S Soleimani, M Shamsi, MA Ghazani, HP Modarres, KP Valente, ... Biotechnology advances 36 (4), 880-893, 2018 | 46 | 2018 |
| Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer S Lheureux, DE Matei, PA Konstantinopoulos, BX Wang, R Gadalla, ... Journal for immunotherapy of cancer 10 (3), 2022 | 38 | 2022 |
| Understanding biophysical behaviours of microfluidic-synthesized nanoparticles at nano-biointerface S Soleimani, MM Hasani-Sadrabadi, FS Majedi, E Dashtimoghadam, ... Colloids and Surfaces B: Biointerfaces 145, 802-811, 2016 | 22 | 2016 |
| TCR clonality and Treg frequency as predictors of outcome in stage III NSCLC treated with durvalumab. SCM Lau, S Soleimani, SWY Wong, S Pedersen, BX Wang, A Elkrief, ... Journal of Clinical Oncology 38 (15_suppl), 3050-3050, 2020 | 2 | 2020 |
| Identification of intratumoral and peripheral T-cell receptor (TCR) repertoire features associated with acquired (Ar) and primary (Pr) resistance to immune checkpoint … S Genta, S Soleimani, X Li, S Pedersen, A Nguyen, AR Abdul Razak, ... JCO Global Oncology 9 (Supplement_1), 59-59, 2023 | | 2023 |
| Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors S Soleimani, BX Wang, S Pedersen, J Eagles, J Brick, MO Butler, ... Cancer Research 83 (7_Supplement), 6667-6667, 2023 | | 2023 |
| cfDNA-based analysis of minimal residual disease and T-cell receptor clonality as predictors of relapse in stage 3 NSCLC treated with chemoradiotherapy and durvalumab SCM Lau, S Soleimani, J Zou, J Burgener, S Kuang, SWY Wong, M Ryan, ... Cancer Research 81 (13_Supplement), 563-563, 2021 | | 2021 |
| P14. 24 Evolution of TCR Clonality during Chemoradiation and Durvalumab as Predictors of Survival in Stage 3 NSCLC S Lau, S Soleimani, S Wong, B Wang, S Pedersen, D Patel, P Bradbury, ... Journal of Thoracic Oncology 16 (3), S340, 2021 | | 2021 |
| Long-term co-culture of endothelial and cancer cells within biomimetic microfluidic chips for investigating juxtacrine and paracrine regulatory signaling pathways S Soleimani | | 2019 |
| Journal Materials Chemistry B A Hosseini, S Soleimani, HP Modarres, SH Emami, M Tondar, ... | | |
